
Identifying and accelerating high impact cancer research at @TheMarkFdn
New York
Joined May 2012
- Tweets446
- Following603
- Followers653
- Likes3.1K
Becky Bish retweeted
Replying to @TheMarkFdn @OSInstitute
A huge thank you to Richard Gorlick, Catherine Bollard, and Patrick Hwu for bringing together an outstanding group of scientists and clinicians and leading two days of deep dives into the data, spirited debate, and new connections. Excited to see the ideas and collaborations that emerge!
Becky Bish retweeted
We've had two thrilling days in Dallas gathering the scientific community for Advancing Immunotherapy for Osteosarcoma, organized with @OSInstitute. The challenges are immense, but so is the potential. Together, we're working toward better treatments for patients who urgently need them.
Becky Bish retweeted
"The Samuel Waxman Institute for Aging & Cancer represents a new era of research in the aging and cancer space." - Ryan Schoenfeld, CEO of the Mark Foundation
Learn more: themarkfoundation.org/waxman…
Becky Bish retweeted
📢Funding Opportunity!📢 The Mark Foundation is now accepting letters of intent for the Endeavor Award.
✅$3 million in cancer research funding over 3 years
✅Open to multidisciplinary teams of 3+ investigators
✅Worldwide call
LOIs are due Sept 3: themarkfoundation.org/endeav…
The annual #AACR25 meeting gets more exciting every year, as the footprint of @TheMarkFdn funded researchers grows. Check out our grantees' presentations here - including Cathy Wu presenting her Endeavor team's cancer vaccines in the plenary now! themarkfoundation.org/blog/m…
Becky Bish retweeted
📢 Funding Opportunity! 📢
The Mark Foundation is now accepting letters of intent for the Emerging Leader Award.
✅$750,000 in cancer #researchfunding over 3 years
✅Open to US & Canadian faculty appointed in calendar years 2017-2022
Learn more: themarkfoundation.org/emergi…
Becky Bish retweeted
How can we accelerate the development of effective cell and gene therapies for #GBM patients? Last week at #ACGT25, The Mark Foundation's @Becky_ABC moderated a panel of brain cancer experts tackling this tough topic. @ACGTFoundation
Becky Bish retweeted
📢We’re hiring a Grants & Data Operations Coordinator!📢
Are you experienced in database management, project coordination, or operations support? Apply to help us advance cancer research! This hybrid, full-time role is based in Manhattan. Learn more: themarkfoundation.org/grants…
Becky Bish retweeted
Interested in applying for an Endeavor Award? We will begin accepting Letters of Intent for our next funding round on June 25, 2025. Learn more about these grants for collaborative, multidisciplinary cancer research projects here: themarkfoundation.org/endeav…
Becky Bish retweeted
#AACR CEO Marge Foti speaks at #recalcitrant #cancers meeting in Philly: For the first time ever, three organizations come together to support this research @AACR @TheMarkFdn @lustgartenfdn
Becky Bish retweeted
The end of the year is approaching! Make your tax-deductible donation to the Mark Foundation before December 31st and support the boldest ideas in cancer research. Donate now: themarkfoundation.org/donate… #YearEndGiving #CancerResearch
Becky Bish retweeted
Are molecular glue degraders having their moment?
In @biospace, Mark Foundation CEO Ryan Schoenfeld shares why he thinks we’re at an inflection point for this promising drug class.
biospace.com/drug-developmen…
Becky Bish retweeted
We’re in Boston for the 1st annual meeting of the @CancerGrand Challenges MATCHMAKERS team! The team, which we sponsor with @CR_UK & @theNCI, is creating tools to predict T cell antigen specificity, which could unlock more effective immunotherapies.
cancergrandchallenges.org/ch…
Becky Bish retweeted
The CSHL School of Biological Sciences is celebrating its 25th anniversary! To mark this milestone, we spoke with 5 of its graduates to hear about their experiences and current endeavors. @CSHLsbs cshl.edu/where-are-they-now/
Becky Bish retweeted
We are excited to share that The Brain Tumor Funders' Collaborative is now accepting applications for innovative brain tumor research projects to advance liquid biopsy technology. The Sontag Foundation is proud to be providing $150,000 in support. Apply: bit.ly/4eBSW5X
#SNO2024 is the perfect follow up for @TheMarkFdn @sontagfdn glioblastoma workshop - reconnecting with attendees and going in depth in so many important topics in brain cancer
Becky Bish retweeted
The #Glioblastoma workshop with @TheMarkFdn was incredible! Thank you to everyone who attended. We’re inspired by the collaboration and progress shared. A huge thank you to our amazing organizers Tim Cloughesy, @kaelin_lab, and @sheilasinghlab for bringing the workshop to life.
Becky Bish retweeted
Thank you so much to the @sbtfoundation @TheMarkFdn @sontagfdn for this wonderful award and opportunity to join the workshop with this brilliant group of leaders in the brain tumor field all dedicated to finding a cure for glioblastoma!!
In addition to our workshop participants, we’re thrilled to welcome talented early-career researchers who join us thanks to the @sbtfoundation Career Development Award! Pictured here: @TylerEMiller @d_bayik @IlonLiu, Kelly Turner of @sbtfoundation & @NajemHinda.
@sontagfdn
Becky Bish retweeted
A great final day at the #glioblastoma workshop with the @TheMarkFdn. We heard from many presenters including David Ashley and @ben_ellingson, who presented data from a project we funded in collaboration with the National Brain Tumor Society.
#sontagfoundation #GBM
Becky Bish retweeted
It was an incredible meeting! Thanks to @TheMarkFdn @sontagfdn and the organizers for the invitation. Two days of outstanding scientific sessions, great panel discussions, ideas & reflections to advance #glioblastoma #gbm research and develop better treatments for patients!
Fantastic @TheMarkFdn @sontagfdn workshop on glioblastoma - bringing together 41 of the top researchers in brain tumors & therapeutics from around the world to figure out how to beat this devastating disease. @sheilasinghlab @kaelin_lab & Tim Cloughesy are fantastic organizers























